EETs activate the MAPK and PI3K/Akt signaling pathways, enhance EGFR phosphorylation, regulate the tumor microenvironment, and facilitate immunosuppression in a number of tumor cell lines following an autocrine and paracrine manner [53]. The gene discussed is AKT1; the disease is neoplasm.